Billion-dollar mergers may have their approvals delayed as the Covid-19 pandemic poses unprecedented challenges to EU investigators charged with collecting market information and conducting probes while respecting companies’ procedural rights.While there is little doubt the European Commission will bend over backwards to accommodate corporate needs, as it did in
* = Required Field
*Areas of Interest
MLex content is primarily organized into different areas of interest that cover the main elements of regulatory risk. Please indicate which ones you would like to be included in your Daily Wrap-up alert
MLex Limited and our LexisNexis Legal & Professional group of companies will use your personal information to administer your account and/or provide the products and services that you have requested from us. We may also contact you in your professional capacity with information about our other products, services and events that we believe may be of interest. You can manage your communication preferences via our Preference Center . You can learn more about how we handle your personal data and your rights by reviewing our Privacy Policy .
Andrew is a reporter covering merger reviews and competition policy for MLex in Brussels. He joined MLex in 2015 and holds a degree and a master’s degree in history from the University of Liverpool.